PM1009

· Biotheus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PM1009, covering 2024-12-16 to 2024-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC [Phase 1, Phase 2]